These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11406628)

  • 1. Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis.
    Sim SP; Liu LF
    J Biol Chem; 2001 Aug; 276(34):31590-5. PubMed ID: 11406628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
    Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
    Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
    Stanulla M; Wang J; Chervinsky DS; Thandla S; Aplan PD
    Mol Cell Biol; 1997 Jul; 17(7):4070-9. PubMed ID: 9199342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
    Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
    Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
    Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot.
    Mirault ME; Boucher P; Tremblay A
    Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
    Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
    Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity.
    Betti CJ; Villalobos MJ; Jiang Q; Cline E; Diaz MO; Loredo G; Vaughan AT
    Leukemia; 2005 Dec; 19(12):2289-95. PubMed ID: 16193084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.
    Lovett BD; Strumberg D; Blair IA; Pang S; Burden DA; Megonigal MD; Rappaport EF; Rebbeck TR; Osheroff N; Pommier YG; Felix CA
    Biochemistry; 2001 Feb; 40(5):1159-70. PubMed ID: 11170441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of MLL gene rearrangement: site-specific DNA cleavage within the breakpoint cluster region is independent of chromosomal context.
    Stanulla M; Chhalliyil P; Wang J; Jani-Sait SN; Aplan PD
    Hum Mol Genet; 2001 Oct; 10(22):2481-91. PubMed ID: 11709535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.
    Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ
    Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the MLL breakpoint cluster region (BCR).
    Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD
    Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA fragility at the
    Cowell IG; Austin CA
    Open Biol; 2023 Jan; 13(1):220232. PubMed ID: 36629017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study.
    Ng A; Taylor GM; Wynn RF; Eden OB
    Leukemia; 2005 Feb; 19(2):253-9. PubMed ID: 15592432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system.
    Betti CJ; Villalobos MJ; Diaz MO; Vaughan AT
    Cancer Res; 2001 Jun; 61(11):4550-5. PubMed ID: 11389089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemias related to treatment with DNA topoisomerase II inhibitors.
    Felix CA
    Med Pediatr Oncol; 2001 May; 36(5):525-35. PubMed ID: 11340607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.
    Ishii E; Eguchi M; Eguchi-Ishimae M; Yoshida N; Oda M; Zaitsu M; Fujita I; Miyazaki S; Hamasaki Y; Mizutani S
    Int J Hematol; 2002 Jul; 76(1):74-9. PubMed ID: 12138900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.